A compound extracted from a deep-water marine sponge is showing potent antibacterial activity against the drug resistant bacteria methicillin-resistant Staphylococcus aureus also called the "super bug."
FAU has received federal designation as a Hispanic-Serving Institution, which only is awarded to colleges and universities with enrollment of full-time Hispanic undergraduate students of at least 25 percent.
Using remote sensing cameras and sound recorders, FAU scientists are the first to capture rare video footage of a newly discovered population of critically endangered monkeys in a remote region in the world.
Researchers from FAU and Sancilio and Company, Inc. are collaborating to develop a treatment for Retinitis Pigmentosa, an inherited disease that causes severe progressive vision impairment and blindness.
Alana Edwards served on review panels to select applications submitted to the Department of Defense to decide how the $5 million appropriated by Congress will be spent on future tick-borne disease research.
Researchers from FAU and Harvard address the possible but unproven link between statins and diabetes and emphasize that the link to diabetes is questionable and inconsequential.
Ramon Garcia-Areas' groundbreaking research on breast cancer has earned him a prestigious post-doctoral fellowship at Institut Curie Pasteur in Paris, one of the world's leading research institutes.
A new study at FAU is the first to demonstrate that the Parkin gene is turned on when cells are exposed to environmental insults that cause free radical formation and cataract formation.
Janet Robishaw, Ph.D., a leader in functional and translational genomics, has been appointed as chair of the Department of Biomedical Sciences in FAU's Charles E. Schmidt College of Medicine.
FAU has entered into a licensing agreement with Neuro Pharmalogics, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases.